Kymera Therapeutics Inc (KYMR)
43.56
-0.49
(-1.11%)
USD |
NASDAQ |
Nov 21, 16:00
43.56
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Price: 43.56 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 42.75 | 44.10 | 42.10 | 44.05 | 385022.0 |
| Nov 19, 2024 | 42.09 | 42.89 | 41.50 | 42.84 | 376677.0 |
| Nov 18, 2024 | 42.03 | 43.08 | 41.12 | 42.41 | 405191.0 |
| Nov 15, 2024 | 45.00 | 45.45 | 41.50 | 41.96 | 827514.0 |
| Nov 14, 2024 | 48.70 | 49.08 | 45.89 | 45.94 | 413692.0 |
| Nov 13, 2024 | 50.79 | 51.14 | 48.63 | 48.63 | 280288.0 |
| Nov 12, 2024 | 51.49 | 52.48 | 49.12 | 50.00 | 308735.0 |
| Nov 11, 2024 | 51.97 | 53.23 | 51.45 | 51.84 | 392413.0 |
| Nov 08, 2024 | 49.91 | 51.13 | 49.39 | 50.95 | 300187.0 |
| Nov 07, 2024 | 49.52 | 50.99 | 48.58 | 49.86 | 439692.0 |
| Nov 06, 2024 | 49.93 | 51.14 | 48.46 | 49.48 | 683480.0 |
| Nov 05, 2024 | 46.98 | 48.88 | 46.34 | 47.69 | 345799.0 |
| Nov 04, 2024 | 46.10 | 47.92 | 45.16 | 47.07 | 303479.0 |
| Nov 01, 2024 | 47.10 | 47.65 | 45.20 | 46.47 | 432609.0 |
| Oct 31, 2024 | 44.75 | 46.98 | 42.62 | 46.17 | 747821.0 |
| Oct 30, 2024 | 48.12 | 48.56 | 47.26 | 47.67 | 293720.0 |
| Oct 29, 2024 | 48.53 | 49.16 | 47.75 | 48.49 | 356814.0 |
| Oct 28, 2024 | 49.01 | 50.29 | 48.84 | 49.08 | 324176.0 |
| Oct 25, 2024 | 49.02 | 49.52 | 47.07 | 47.99 | 430325.0 |
| Oct 24, 2024 | 48.95 | 49.79 | 48.37 | 48.73 | 282022.0 |
| Oct 23, 2024 | 48.25 | 49.33 | 47.50 | 48.76 | 561263.0 |
| Oct 22, 2024 | 46.48 | 48.58 | 45.75 | 48.37 | 305977.0 |
| Oct 21, 2024 | 46.23 | 46.88 | 45.54 | 46.56 | 281501.0 |
| Oct 18, 2024 | 46.58 | 46.98 | 45.71 | 46.41 | 222936.0 |
| Oct 17, 2024 | 48.89 | 49.42 | 46.18 | 46.25 | 290612.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
10.97
Minimum
Oct 27 2023
87.83
Maximum
Dec 28 2020
37.70
Average
35.64
Median
Mar 29 2021
Price Benchmarks
| Amgen Inc | 289.88 |
| Voyager Therapeutics Inc | 5.425 |
| Denali Therapeutics Inc | 24.26 |
| Vir Biotechnology Inc | 6.965 |
| Avidity Biosciences Inc | 42.55 |
Price Related Metrics
| PS Ratio | 34.63 |
| Price to Book Value | 3.159 |
| Earnings Yield | -5.37% |
| Market Cap | 2.821B |